These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3315283)

  • 41. [Prognostic significance of systemic clearance of methotrexate in acute lymphoid leukemia in childhood].
    Borsi J; Révész T; Schuler D
    Orv Hetil; 1986 Feb; 127(8):439-42. PubMed ID: 3456552
    [No Abstract]   [Full Text] [Related]  

  • 42. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
    Chessells JM; Durrant J; Hardy RM; Richards S
    J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical Research Council leukaemia trial, UKALL VII. A report to the Council by the Working Party on Leukaemia in Childhood.
    Arch Dis Child; 1985 Nov; 60(11):1050-4. PubMed ID: 3907505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of methotrexate given intrathecally to children with acute lymphoblastic leukemia.
    Skibińska L; Daszkiewicz P; Michalewska D; Radwańska U
    Pol J Pharmacol Pharm; 1988; 40(2):135-43. PubMed ID: 3237563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of two methods of maintenance chemotherapy with methotrexate and 6-mercaptopurine for childhood acute lymphoblastic leukemia].
    Kawai S; Fujimoto T; Hiyoshi Y; Nibu K; Ito M; Kadoya S; Shingaki Y
    Rinsho Ketsueki; 1984 Jun; 25(6):819-26. PubMed ID: 6384569
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis.
    Brooks PJ; Spruill WJ; Parish RC; Birchmore DA
    Arthritis Rheum; 1990 Jan; 33(1):91-4. PubMed ID: 2302272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New treatment schedule with improved survival in childhood leukemia. Intermittent parenteral vs daily oral administration of methotrexate for maintenance of induced remission. Acute leukemia group B.
    JAMA; 1965 Oct; 194(1):75-81. PubMed ID: 5896942
    [No Abstract]   [Full Text] [Related]  

  • 48. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
    Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
    Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Change in transfer rate of methotrexate from spinal fluid to plasma during intrathecal therapy in children and adults.
    Lankelma J; Lippens RJ; Drenthe-Schonk A; Termond EF; van der Kleijn E
    Clin Pharmacokinet; 1980; 5(5):465-75. PubMed ID: 6931669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood.
    Gwavava NJ; Pinkerton CR; Glasgow JF; Sloan JM; Bridges JM
    J Clin Pathol; 1981 Jul; 34(7):790-5. PubMed ID: 6943149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic determinants of 6-mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia.
    Sulh H; Koren G; Whalen C; Soldin S; Zipursky A; Greenberg M
    Clin Pharmacol Ther; 1986 Dec; 40(6):604-9. PubMed ID: 3465489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronopharmacokinetics of oral methotrexate and 6-mercaptopurine: is there diurnal variation in the disposition of antileukemic therapy?
    Balis FM; Jeffries SL; Lange B; Murphy RF; Doherty KM; Arndt CA; Luery N; Poplack DG
    Am J Pediatr Hematol Oncol; 1989; 11(3):324-6. PubMed ID: 2782561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacokinetics of methotrexate in children with acute lymphoblastic leukemia].
    Lares-Asseff I; Paredes R; Taboada C; Cravioto J; Velázquez M; Roldán RM; Faisal AG
    Bol Med Hosp Infant Mex; 1988 Oct; 45(10):671-80. PubMed ID: 3264171
    [No Abstract]   [Full Text] [Related]  

  • 54. Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
    Haghbin M; Tan CC; Clarkson BD; Miké V; Burchenal JH; Murphy ML
    Cancer; 1974 Jun; 33(6):1491-8. PubMed ID: 4526012
    [No Abstract]   [Full Text] [Related]  

  • 55. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?
    Chan BS; Dawson AH; Buckley NA
    Clin Toxicol (Phila); 2017 Feb; 55(2):88-96. PubMed ID: 28084171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse.
    Brecher ML; Weinberg V; Boyett JM; Sinks LF; Jones B; Glicksman A; Holland JF; Freeman AI
    Cancer; 1986 Sep; 58(5):1024-8. PubMed ID: 3524797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of acute lymphoblastic leukaemia: effect of variation in length of treatment on duration of remission. Report to the Medical Research Council by the Working Party on Leukaemia in Childhood.
    Br Med J; 1977 Aug; 2(6085):495-7. PubMed ID: 329946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: better in the evening.
    Rivard GE; Infante-Rivard C; Hoyoux C; Champagne J
    Lancet; 1985 Dec; 2(8467):1264-6. PubMed ID: 2866334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.